GLP-1 RA Synthesis Process for Robust, Scalable Manufacturing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing processes for synthesizing GLP-1 receptor agonists like GLPIRA are not robust, efficient, or scalable, necessitating the development of an alternative process that addresses these limitations.

Innovation Solution

A multi-step chemical process involving specific intermediates and reactions, including the use of compounds such as CDI, (R)-4-benyl-2-oxazolidone, and copper-mediated additions, to synthesize GLPIRA, utilizing various solvents and catalysts to optimize yield and scalability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the existing synthetic process for GLPIRA is used, then the compound can be prepared, but the process is not robust, efficient, or scalable

Engineering Contradiction:
Improveprocess robustnessVSAvoidmanufacturing scalability
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The synthesis process is divided into multiple discrete steps with specific intermediates (compounds 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100), allowing each step to be optimized independently for robustness and scalability

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The process employs specific reaction conditions including temperature ranges (e.g., -78°C to 0°C for lithiation steps, room temperature for coupling reactions), solvent selections (THF, DMF, DCM), and catalyst amounts (e.g., 0.01-1 equivalent of lithium chloride, 0.01-1 equivalent of copper(I) iodide) to optimize both robustness and scalability at each stage

Inventive Principle:
Principle #35Parameter changes

2Productivity

If the existing synthetic process is used, then GLPIRA can be synthesized, but the yield is lower

Engineering Contradiction:
Improvesynthesis yieldVSAvoidmaterial efficiency
Core Design Contradiction:
ProductivityVSLoss of energy

Solution Approach 1:

Protecting groups are introduced in advance at strategic positions (e.g., benzyl protection at the indole nitrogen, acetyl protection at the carboxylic acid) to prevent unwanted reactions and enable higher yielding subsequent steps, with these groups removed in final deprotection steps

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

Multiple well-defined intermediates are used as mediators to transfer functionality efficiently: compound 4 (acid chloride) mediates the formation of compound 5, compound 6 (alcohol) mediates formation of compound 7, and each intermediate is optimized for the next transformation to maximize overall yield

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new process enhances the robustness, efficiency, and scalability of GLPIRA synthesis, providing higher yields and improved production capabilities.

Implementation Method 1

a copper mediated addition of 2-methyl allyl magnesium chloride in the presence of lithium chloride to compound 4 to give compound 5

Methodology Applied
Scientific EffectCopper-mediated addition: Catalysis

Implementation Method 2

copper mediated addition of 2-methyl allyl magnesium chloride... to compound 4 to give compound 5

Methodology Applied
Scientific EffectNucleophilic addition: Chemical Bonding

Implementation Method 3

The cyclization of compound 6 to compound 7... In one embodiment of the reaction from compound 5 to compound 6, the reaction step comprises reducing compound 5 with lithium borohydride to give compound 6

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 4

The cyclization of compound 6 to compound 7 using p-toluenesulfonic acid monohydrate in a solvent such as cyclopentyl methyl ether

Methodology Applied
Scientific EffectAcid catalysis: Catalysis

Implementation Method 5

A reactor was charged with compound 7 and chloroacetonitrile... Potassium hydroxide and catalytic tetrabutylammonium chloride hydrate were added... to give compound 8

Methodology Applied
Scientific EffectNucleophilic substitution: Chemical Bonding

Implementation Method 6

Lithium t-butoxide was added... to give compound 10

Methodology Applied
Scientific EffectBase deprotonation: Catalysis

Implementation Method 7

The mixture was treated with hydroxylamine... to give compound 10

Methodology Applied
Scientific EffectNucleophilic attack: Chemical Bonding

Implementation Method 8

The mixture was treated with carbon disulfide and a base... to give compound 11

Methodology Applied
Scientific EffectCondensation: Chemical Bonding

Implementation Method 9

The mixture was treated with carbon disulfide and a base... to give compound 11

Methodology Applied
Scientific EffectCyclization: Chemical Bonding

Implementation Method 10

The mixture was treated with sodium t-butoxide and water... to give compound 12

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS12365682B2Process to make GLP1 RA and intermediates therefor
Publication Date: 2025.07.22 ELI LILLY & CO
  • US12365682B2 patent drawing
  • US12365682B2 patent drawing
  • US12365682B2 patent drawing

AI summary

The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl ]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds.